Reliq Health Technologies, Inc. Announces that it has Resumed Onboarding at Remote Health Clinics and Federally Qualified Health Centers as US COVID Cases Drop
Reliq Health Technologies Inc. (OTC:RQHTF) has resumed onboarding with Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) following a decline in COVID-19 cases in the US. The company aims to onboard over 27,000 patients in the next year, utilizing its Remote Patient Monitoring and other services. Expected revenue is approximately $50 per patient monthly. Reliq's iUGO Care platform supports better healthcare access and patient outcomes, vital for the company's growth in the telemedicine sector.
- Resumed onboarding with over 27,000 RHC and FQHC patients expected within 12 months.
- Projected average revenue of $50 per patient per month.
- None.
HAMILTON, Ontario, May 26, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has resumed onboarding with Rural Health Clinics and Federally Qualified Health Centers thanks to the significantly reduced COVID numbers in the US.
“Remote Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) were on the front lines during the pandemic, providing COVID testing, treatment, and more recently serving as COVID vaccination sites for local communities,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies. “There are over 4,500 RHCs and FQHCs across the US. Remote Health Clinics provide primary care services to Medicare patients in rural and underserved or 'shortage' areas. Federally Qualified Health Centers provide both primary care and dental care services to rural, urban and shortage areas. After pausing onboarding at our RHC and FQHC client sites at the start of the pandemic in March 2020, we are now pleased to announce that onboarding has resumed with these clients. We expect to onboard over 27,000 RHC and FQHC patients over the next 12 months. These healthcare organizations will be using Reliq’s Remote Patient Monitoring (RPM), Chronic Care Management (CCM), Behavioral Health Integration (BHI) and Transitional Care Management services to help improve patient health outcomes and enhance access to care. We expect to generate an average revenue of
Reliq Health
Reliq Health Technologies is a rapidly growing global telemedicine company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company Contact
Investor Relations at ir@reliqhealth.com
US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, and uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
FAQ
What is Reliq Health Technologies' latest announcement regarding RQHTF?
When did Reliq Health pause onboarding with RHCs and FQHCs?
How much revenue does Reliq Health expect per patient?
What services will be provided to patients by Reliq Health?
